GHK-Cu 100 mg Dosage Protocol

What is GHK-Cu?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. It plays a pivotal role in extracellular matrix (ECM) remodeling, collagen and elastin synthesis, tissue repair, and antioxidant defense mechanisms.

While human clinical research has predominantly focused on topical creams, serums, and wound-care gels (such as diabetic ulcer healing and post-laser skin resurfacing), subcutaneous research protocols are widely utilized in practice conventions for systemic tissue regeneration, skin quality improvement, and cellular repair signaling.

Endogenous levels of GHK-Cu decline significantly with age—dropping by over 60% by age 60—making exogenous supplementation a focal point in anti-aging, dermatology, and regenerative research.

Potential Areas of Research

Collagen & Elastin Synthesis: Extensively studied for stimulating fibroblast activity and upregulating collagen, elastin, and glycosaminoglycan production.
Extracellular Matrix Remodeling: Researched for its ability to regulate matrix metalloproteinases (MMPs) and their inhibitors, aiding proper wound healing and tissue repair.
Antioxidant & Anti-Inflammatory Pathways: Profiled for quenching free radicals, lowering pro-inflammatory cytokines, and promoting tissue-protective gene expression.
Dermatological & Hair Follicle Health: Examined in topical and systemic literature for improving skin density, elasticity, clarity, and hair follicle support.

GHK-Cu 100 mg Dosage Protocols

Vial Size: 100 mg (100,000 mcg)
Reconstitution: 3.0 mL Sterile or Bacteriostatic Water
Concentration: 33.33 mg/mL (~333.3 mcg per U-100 Syringe Unit)
Administration Route: Subcutaneous Injection

Protocol Options & Dosage Charts

Weeks

Daily Dose

Syringe Units (U-100 / 1mL Syringe)

Weeks 1–4

1.0 mg (1,000 mcg)

3 Units

Weeks 5–8

1.5 mg (1,500 mcg)

4.5 Units

Weeks 9–12+

2.0 mg (2,000 mcg)

6 Units

Vial Lifespan & Calculations:
Reconstituting a 1000 mg (100 mg) vial with 3.0 mL yields a concentration of 33.33 mg/mL. Because unit measurements at this concentration are very small (3 to 6 units), using standard U-100 insulin syringes with clear half-unit or single-unit hash marks is recommended for exact dosing. One 100 mg vial lasts approximately 8 to 12 weeks depending on the selected schedule.

Protocol Supply Calculations

Option A (5 Days / Week)

GHK-Cu 100 mg Vials: 1 vial for 8 weeks (~50 mg used); 1 vial for 12 weeks (~90 mg used); 2 vials for 16 weeks (~130 mg used).
Insulin Syringes (U-100, 29–31G): 40 syringes for 8 weeks; 60 syringes for 12 weeks; 80 syringes for 16 weeks (5 per week).
Bacteriostatic Water: 1 × 10 mL bottle (3.0 mL per vial reconstituted).
Alcohol Swabs: 80 swabs for 8 weeks; 120 swabs for 12 weeks; 160 swabs for 16 weeks (2 per injection: 1 for vial stopper, 1 for skin site).

Option B (3 Days / Week)

GHK-Cu 100 mg Vials: 1 vial covers up to 16 weeks (~96 mg used).
Insulin Syringes (U-100, 29–31G): 24 syringes for 8 weeks; 36 syringes for 12 weeks; 48 syringes for 16 weeks (3 per week).
Bacteriostatic Water: 1 × 10 mL bottle.
Alcohol Swabs: 48 swabs for 8 weeks; 72 swabs for 12 weeks; 96 swabs for 16 weeks

Reconstitution Steps

Sanitize Equipment
Clean the rubber stoppers of both the bacteriostatic water vial and the 100 mg GHK-Cu vial using fresh alcohol swabs. Allow to air-dry completely.
Draw Diluent
Using a sterile mixing syringe, draw up exactly 3.0 mL of bacteriostatic or sterile water.
Add Liquid Slowly
Insert the needle into the GHK-Cu vial at an angle, directing the liquid slowly down the glass wall of the vial. Avoid spraying directly onto the powder cake to prevent excessive foaming.
Gently Dissolve
Gently roll or swirl the vial between your hands until the powder completely dissolves into a clear, light-blue solution. Do not shake vigorously.
Label and Store
Label the vial with the preparation date and concentration (33.33 mg/mL). Refrigerate immediately at 2–8°C (35.6–46.4°F), protected from light exposure.

Storage & Handling

Unreconstituted (Dry Powder): Store long-term in a freezer at −20°C (−4°F) or below, in a dark, dry environment.
Reconstituted Solution: Store in a refrigerator at 2–8°C (35.6–46.4°F). Keep protected from UV light and minimize unnecessary temperature fluctuations or repeat freeze-thaw cycles.
Inspection: Before each pull, inspect the liquid. Reconstituted GHK-Cu has a characteristic faint blue tint due to the copper complex. Discard if significant cloudiness, particulates, or unusual discoloration appears.

Technical Research Note

Because of its potent mechanism of stimulating the pituitary gland, prolonged application requires systematic tracking of elevated IGF-1 baselines. Preclinical data indicates that rapid titration or high baseline saturation can introduce transient, dose-dependent side effects such as mild joint soreness (arthralgia), muscle aches, and peripheral edema. Additionally, because growth hormone alters carbohydrate metabolism, close observation of blood glucose parameters and HbA1c shifts is recommended in metabolic research models. Tesamorelin is strictly contraindicated in models presenting active cellular malignancies due to the theoretical potential of GH/IGF-1 to stimulate cellular proliferation.

Administration & Injection Technique

Route: Subcutaneous injection into healthy adipose tissue (e.g., lower abdomen at least 2 inches away from the navel, outer upper thigh, or back of the upper arm).
Technique: Clean the site with an alcohol swab and allow to dry. Pinch a skin fold, insert a fine-gauge (29–31G) U-100 insulin syringe at a 45° to 90° angle, and depress the plunger steadily over 5–10 seconds.
Site Rotation: Rotate injection sites regularly to avoid localized skin irritation or lipohypertrophy.
Post-Injection Handling: Dispose of used single-use needles immediately into an approved, puncture-proof sharps container.

Technical Notes & Observational Context

Localized Stinging / Soreness: Subcutaneous injections of copper peptides can occasionally cause minor localized post-injection stinging or tightness. Administering slowly and ensuring the solution reaches room temperature right before injection can help minimize discomfort.
Syringe Precision: Because 1.0 mg is represented by only 3 U-100 units at a 33.33 mg/mL concentration, precise unit measurement is important.

Regulatory Compliance Disclaimer

IMPORTANT NOTICE: This content is intended exclusively for educational and research purposes. GHK-Cu is provided for laboratory research use only and is not approved for human consumption, diagnosis, or self-treatment. This material does not constitute medical advice. Always consult with a licensed healthcare professional regarding any medical or clinical protocols.

View Supplier

References

— Clinical evaluation of topical glycyl-L-histidyl-L-lysine copper in the treatment of diabetic ulcers.

— Evaluation of topical copper tripeptide complex following carbon dioxide laser resurfacing.

— Comparative evaluation of topical cream formulations incorporating a copper-binding peptide complex.

— Split-face evaluation of a GHK-Cu nano-serum on collagen, elastin, and wrinkle-associated skin outcomes.

— GHK-associated regulation of matrix metalloproteinase-2 (MMP-2) expression.

— Phase 2 clinical evaluation of topical GHK-Cu gel for the treatment of acute skin wounds.

— Safety considerations for compounded formulations, including injectable GHK-Cu preparations.

— Route-specific regulatory evaluation of GHK-Cu as a bulk drug substance.

Iamin Gel topical wound-dressing device record.